EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.1.27.8 | Atherosclerosis |
34259011 |
Endonuclease V Regulates Atherosclerosis Through C-C Motif Chemokine Ligand 2-Mediated Monocyte Infiltration. |
causal interaction
ongoing research
unassigned |
4
4
0 |
| 3.1.27.8 | Carcinoma, Hepatocellular |
32083667 |
Deletion of Endonuclease V suppresses chemically induced hepatocellular carcinoma. |
diagnostic usage
therapeutic application
unassigned |
1
1
0 |
| 3.1.27.8 | Cockayne Syndrome |
9372849 |
Incomplete complementation of the DNA repair defect in cockayne syndrome cells by the denV gene from bacteriophage T4 suggests a deficiency in base excision repair. |
therapeutic application
unassigned |
1
0 |
| 3.1.27.8 | Infections |
6814534 |
Are pyrimidine dimers tolerated during DNA replication of UV-irradiated parvovirus minute-virus-of-mice in mouse fibroblasts? |
unassigned |
0 |
| 3.1.27.8 | Neoplasms |
2157863 |
Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells. |
ongoing research
unassigned |
3
0 |
| 3.1.27.8 | Neoplasms |
19043748 |
Modeling of Escherichia coli Endonuclease V structure in complex with DNA. |
therapeutic application
unassigned |
1
0 |
| 3.1.27.8 | Neoplasms |
32083667 |
Deletion of Endonuclease V suppresses chemically induced hepatocellular carcinoma. |
diagnostic usage
therapeutic application
unassigned |
1
1
0 |
| 3.1.27.8 | Stroke |
34259011 |
Endonuclease V Regulates Atherosclerosis Through C-C Motif Chemokine Ligand 2-Mediated Monocyte Infiltration. |
causal interaction
ongoing research
unassigned |
4
4
0 |
| 3.1.27.8 | Xeroderma Pigmentosum |
197527 |
Specific action of T4 endonuclease V on damaged DNA in xeroderma pigmentosum cells in vivo. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
| 3.1.27.8 | Xeroderma Pigmentosum |
1665912 |
Enhancement of ultraviolet-DNA repair in denV gene transfectants and T4 endonuclease V-liposome recipients. |
ongoing research
therapeutic application
unassigned |
4
1
0 |
